Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 09, 2016 16:01 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Provides Corporate Update, Fourth Quarter and Full Year 2015 Financial Results

Fispemifene Phase 2b Top-Line Data Expected By End of Q1 2016Vitaros Quarterly Unit Sales Increased 23% in EuropeConference Call / Webcast Today, Wednesday, March 9, 2016 at 5:00 p.m. ET SAN DIEGO,...
March 08, 2016 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences to Present at the 28th Annual ROTH Conference

SAN DIEGO, March 08, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that...
March 04, 2016 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Closes $10 Million Registered Direct Offering

SAN DIEGO, March 04, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that...
March 02, 2016 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Corporate Update, Fourth Quarter and Full Year 2015 Financial Results Conference Call

SAN DIEGO, March 02, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced...
March 01, 2016 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences to Present at the Cowen and Company 36th Annual Health Care Conference

SAN DIEGO, March 01, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that...
February 02, 2016 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences to Present at the 18th Annual BIO CEO & Investor Conference

SAN DIEGO, Feb. 02, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that...
January 13, 2016 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces $10 Million Registered Direct Offering

SAN DIEGO, Jan. 13, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that...
January 06, 2016 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Year-End 2015 Update and 2016 Growth Strategy

SAN DIEGO, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today reviewed its 2015...
December 01, 2015 12:41 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Confirms Clinical Strategy for Its Novel Treatment for Symptomatic Secondary Hypogonadism Fispemifene

Apricus Expects to Report Top-Line Phase 2b Data in Q1 2016 SAN DIEGO, Dec. 1, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative...
November 17, 2015 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Named to Deloitte's 2015 Technology Fast 500(TM) List of Fastest Growing Companies in North America

SAN DIEGO, Nov. 17, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it...